home / stock / cmnd / cmnd quote
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $1.192 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 02/12/2020 04:30:27 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 02-12-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 02-11-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 02-10-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 02-07-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 02-06-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 02-05-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 02-04-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 02-03-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 01-31-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 01-30-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 01-29-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 01-28-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 01-27-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 01-24-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 01-23-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 01-22-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 01-21-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 01-20-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 01-17-2020 |
$ | $N/A | $1.192 | $N/A | $N/A | 0 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 78.0% to $0.58749 on volume of 130,454,575 shares Ocean Power Technologies Inc. (OPTT) rose 29.6% to $0.2073 on volume of 51,927,154 shares Cosmos Health Inc. (COSM) rose 64.9% to $1.12 on volume of...
Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated healt...
Vancouver, Canada, June 20, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated healt...